Medios AG

“Hauptstadtkongress 2024”: Medios hosts symposium on ‘Security of supply”

Medios AG: Successful sale of shares from Company founder Manfred Schneider to Luxempart S.A.

Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

Hauck & Aufhäuser starts coverage of Medios AG with buy recommendation and price target of €23.00

Medios AG successfully completes acquisition of Ceban, significantly expanding its market position in Europe

Medios AG records further revenue growth in the first quarter of 2024 and confirms full-year guidance

Medios AG: Constantijn van Rietschoten appointed Executive Board member for International Markets

Medios achieves double-digit growth in 2023 – Positive outlook for 2024

Medios acquires Dutch market leader in pharmaceutical compounding services

Medios acquires Dutch market leader in pharmaceutical compounding services

Medios AG: Supervisory Board extends contracts with members of the Executive Board Mi-Young Miehler and Christoph Prußeit

Medios records strongest quarter in the Company’s history

Medios AG: Strong operating cash flow – record figures as expected also for revenue and earnings in the third quarter of 2023

Medios AG: achieves further growth in the first half of 2023 and expects strong third quarter

Medios AG: Christoph Prußeit, buy

Medios AG: Annual General Meeting re-elects Dr. Yann Samson, Joachim Messner and Klaus J. Buß to the Supervisory Board

Medios AG centralizes blister business at one site and sells Kölsche Blister GmbH